{"prompt": "['CLINICAL STUDY PROTOCOL', 'Study Title:', 'A Multi-Center, Double-Blind, Sham-Controlled, Randomized', 'Trial of Dual Field PEMF Therapy [Provant Therapy System]', 'in Lower Extremity Painful Diabetic Distal Symmetric', 'Peripheral Neuropathy (DSPN) (The RELIEF Trial)', 'Protocol Number:', 'RBI.2017.002', 'Version:', 'C', 'Phase:', 'III', 'Principal Investigator:', 'Leslie J. Klaff, M.D., Ph.D., FRCP (Edin), FACE', 'Sponsor:', 'Regenesis Biomedical, Inc.', '5301 N. Pima Road, Suite 150', 'Scottsdale, AZ 85250', 'Final Protocol:', 'July 17, 2018', '710-7105-01 C', 'RBI.2017.002 Version C', 'CONFIDENTIAL']['2', 'PROTOCOL SIGNATURE PAGE - SPONSOR', 'Study Title:', 'A Multi-Center, Double-Blind, Sham-Controlled, Randomized', 'Trial of Dual Field PEMF Therapy [Provant Therapy System]', 'in Lower Extremity Painful Diabetic Distal Symmetric', 'Peripheral Neuropathy (DSPN) (The RELIEF Trial)', 'Protocol Number:', 'RBI.2017.002', 'Version:', 'C', 'The undersigned acknowledges that he/she has received and read Protocol RBI.2017.002,', 'Version C, dated 17JUL2018.', 'Sponsor Representatives', 'Signature', 'Date', 'Scott Brooks', 'Chief Executive Officer', 'Jamie Muhlenfeld', 'Director of Clinical Research', '710-7105-01 C', 'RBI.2017.002 Version C', 'CONFIDENTIAL']['3', 'PROTOCOL SIGNATURE PAGE - INVESTIGATOR', 'Study Title:', 'A Multi-Center, Double-Blind, Sham-Controlled, Randomized', 'Trial of Dual Field PEMF Therapy [Provant Therapy System]', 'in Lower Extremity Painful Diabetic Distal Symmetric', 'Peripheral Neuropathy (DSPN) (The RELIEF Trial)', 'Protocol Number:', 'RBI.2017.002', 'Version:', 'C', 'The undersigned acknowledges that he/she has received and read Protocol RBI.2017.002,', 'Version C, dated 17JUL2018.', 'Investigator Name (printed)', 'Signature', 'Date', '710-7105-01 C', 'RBI.2017.002 Version C', 'CONFIDENTIAL']\n\n###\n\n", "completion": "END"}